Send feedback

AP1S3 p.Phe4Cys

c.11T>G · rs116107386 · VCV160376

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 4 submitters
AlphaMissense
likely pathogenic
0.7859 · ACMG-weighted
gnomAD v4.1
Rare
low-frequency (popmax 1.34%, nfe)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
1
psoriasis 15, pustular, susceptibility to

Computational evidence

Protein change
AlphaMissense0.7859likely pathogenic
REVEL0.619indeterminate
SaProtLLR -11.56damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL is indeterminate.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 11GERP 1.9, phastCons 1
Regional constrainto/e 0.84unconstrained · MANE · 79 kb · p 0.028 · regional, not allelic
Overall
CADD28.4PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 1.34% European (non-Finnish) · 15,859/1,179,680 alleles
Filtering AF 1.33% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.32%
Overall 1.08% 17,504/1,613,370 alleles · low-frequency exomes 16,188/1,461,064 · genomes 1,316/152,306 · joint denominator
Ancestry group Frequency 1 in
Amishnot grpmax-eligible 2.08% 48
European (non-Finnish)grpmax 1.34% 74
Remaining individualsnot grpmax-eligible 0.797% 125
Admixed American 0.594% 168
Finnishnot grpmax-eligible 0.452% 221
Ashkenazi Jewishnot grpmax-eligible 0.436% 229
Middle Eastern 0.396% 252
African / African-American 0.224% 447
South Asian 0.176% 568
East Asian 0.00446% 22,423

Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
AP1S3
Protein
p.Phe4Cys
Coding
c.11T>G
MANE Select
NM_001039569
dbSNP
rs116107386
Type
single nucleotide variant
Location
chr2:223777862 (GRCh38)
Gene constraint
LOEUF 0.817 · pLI 0.07 (gnomAD)
Structure
AlphaFold pLDDT 93.61 · 20 PDB
Residue 4
a β-strand; a UniProt-annotated variant site (risk factor for psors15; results in decreased protein levels)
Full AP1S3 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ap1s3-p-phe4cys (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown